Showcases Stock ranks Forex

Arcutis Biotherapeutics Inc (ARQT)
24.88  -0.27 (-1.07%) 08-08 16:00
Open: 25.24 Pre. Close: 25.15
High: 25.58 Low: 24.04
Volume: 504,647 Market Cap: 1,466M
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 25.595 - 25.725 25.725 - 25.826
Low: 23.747 - 23.879 23.879 - 23.981
Close: 24.666 - 24.893 24.893 - 25.067
Stock Technical Analysis
Target: Six months: 30.52
One year: 35.65
Support: Support1: 22.00
Support2: 19.44
Resistance: Resistance1: 26.13
Resistance2: 30.52
Pivot: 22.89
Moving Averages: MA(5): 23.27
MA(20): 23.16
MA(100): 21.04
MA(250): 19.90
MACD: MACD(12,26): 0.33
Signal(12,26,9): 0.15
%K %D: %K(14,3): 90.04
%D(3): 70.67
RSI: RSI(14): 57.25
52-Week: High: 26.13
Low: 13.59
Change(%): 29.0
Average Vol(K): 3-Month: 602
10-Days: 1178
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.

[ ARQT ] has closed below upper band by 20.5%. Bollinger Bands are 55.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
Stock chart
Stock News
Thu, 04 Aug 2022
Morgan Stanley Increases Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $45.00 - Defense World

Tue, 02 Aug 2022
Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire

Tue, 02 Aug 2022
Arcutis Biotherapeutics (NASDAQ:ARQT) PT Raised to $50.00 - MarketBeat

Fri, 29 Jul 2022
FDA Approves Arcutis' ZORYVE™ (Roflumilast) Cream 0.3% For - GlobeNewswire

Mon, 25 Jul 2022
DekaBank Deutsche Girozentrale Raises Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) - Defense World

Mon, 11 Jul 2022
Arcutis Biotherapeutics Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis - GlobeNewswire

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 51.42
Shares Float (M)
% Held by Insiders 4.32
% Held by Institutions 90.78
Shares Short (K) 3920
Shares Short Prior Month (K) 3300
Stock Financials
EPS -4.670
Book Value (p.s.) 5.920
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio -5.33
PEG Ratio -0.40
Price to Book value 4.20
Price to Sales
Price to Cash Flow
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android